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Introduction
The Mps1 protein kinase plays an essential role in the spindle as-
sembly checkpoint (SAC; Weiss and Winey, 1996), an inhibitory 
network that restrains anaphase until all kinetochores are stably 
attached to spindle microtubules (Musacchio and Salmon, 2007). 
Recent efforts have revealed that its catalytic activity is required 
for SAC function and chromosome alignment (Jelluma et al., 
2008a,b; Tighe et al., 2008; Kwiatkowski et al., 2010; Sliedrecht 
et al., 2010; see Santaguida et al. in this issue). Exactly how Mps1 
does this is unclear; although its SAC function is linked to kineto-
chore recruitment of Mad1 and Mad2 (Martin-Lluesma et al., 
2002; Liu et al., 2003), Mps1 has also been implicated in aurora B   
regulation (Jelluma et al., 2008b), possibly explaining its role in 
chromosome alignment.
Previously,  when  we  used  an  RNAi  complementation   
assay to inhibit Mps1’s catalytic activity, Mad2 was largely un-
detectable at kinetochores (Tighe et al., 2008). However, Mad1 
recruitment was only partially affected, suggesting two possi-
bilities: either Mps1 recruits Mad1 via a noncatalytic role or 
only low level Mps1 activity is required for Mad1 recruitment. 
Either way, because Mad1 directly recruits Mad2 to the kineto-
chore (Chung and Chen, 2002), the simplest explanation was 
that Mps1 activity promotes the Mad1–Mad2 interaction.
This notion is at odds with current views of Mad2 function 
(Mapelli et al., 2007). The Mad2 template model posits that a Mad1 
dimer acts as the kinetochore receptor for Mad2, which can adopt 
two conformations, open (O-Mad2) and closed (C-Mad2). When 
Mad2 binds Mad1, it adopts the closed conformation, forming the 
Mad1–C-Mad2 core complex. Because Mad2 can dimerize, this 
core complex in turn recruits two O-Mad2 molecules. These are 
handed over to Cdc20, and in doing so, Mad2 closes, generating 
two  Cdc20–C-Mad2  complexes.  Because  the  Mad1–C-Mad2 
complex is very stable (Howell et al., 2004; Shah et al., 2004; Vink 
et al., 2006) and probably present in interphase where it binds the 
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ps1 is an essential component of the spindle 
assembly checkpoint. In this study, we describe 
a novel Mps1 inhibitor, AZ3146, and use it to 
probe the role of Mps1’s catalytic activity during mitosis. 
When Mps1 is inhibited before mitotic entry, subsequent 
recruitment of Mad1 and Mad2 to kinetochores is abol-
ished. However, if Mps1 is inhibited after mitotic entry, 
the  Mad1–C-Mad2  core  complex  remains  kinetochore 
bound, but O-Mad2 is not recruited to the core. Although 
inhibiting Mps1 also interferes with chromosome align-
ment, we see no obvious effect on aurora B activity.   
In contrast, kinetochore recruitment of centromere protein E   
(CENP-E),  a  kinesin-related  motor  protein,  is  severely 
impaired. Strikingly, inhibition of Mps1 significantly in-
creases its own abundance at kinetochores. Furthermore, 
we show that Mps1 can dimerize and transphosphory-
late in cells. We propose a model whereby Mps1 trans-
phosphorylation results in its release from kinetochores, 
thus facilitating recruitment of O-Mad2 and CENP-E and 
thereby  simultaneously  promoting  checkpoint  signaling 
and chromosome congression.
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inhibitor that was modified to enhance potency and selectiv-
ity, resulting in AZ3146 (Fig. 1 A). In in vitro kinase assays, 
AZ3146 inhibited human Mps1
Cat with an IC50 (50% inhibi-
tory concentration) of 35 nM (Fig. 1, B and D). AZ3146 
also efficiently inhibited autophosphorylation of full-length 
Mps1  immunoprecipitated  from  human  cells  (Fig.  1  C). 
Screening a panel of 50 other kinases demonstrated minimal 
activity against 46 enzymes (Fig. 1 E). Only four kinases 
were  inhibited  by  >40%,  namely  FAK,  JNK1,  JNK2,  and 
KIT. Together, these data suggest that AZ3146 is a reasonably 
potent and selective Mps1 inhibitor. To measure the effect   
on Mps1 in cells, we used Phos tag gels to resolve phos-
phorylated isoforms (Kinoshita et al., 2006). When isolated 
from mitotic cells, Mps1 appeared as a major band and a   
minor, slower-migrating band (Fig. 1 F). Upon exposure to 
AZ3146, the minor band largely disappeared, demonstrating 
that  it  clearly  inhibits  phosphorylation  of  Mps1  in  cells   
(Fig. 1 F and Fig. S1 B). Mitotic-specific phospho forms of 
aurora B and BubR1 were not affected by AZ3146 (Fig. S1 C),   
and AZ3146 did not inhibit Cdk1 or aurora B in mitotic cells 
(Fig. S1, A and D).
nuclear envelope (Campbell et al., 2001), it seems unlikely that 
Mps1 promotes binding of Mad2 to Mad1.
An alternative explanation comes from the fact that our ob-
servations were derived using an antibody against Mad2, called 
SM2.2 (Tighe et al., 2008). Because kinetochore-bound Mad2   
effectively represents two different species, we reasoned that the   
effect observed in Mps1-deficient cells was not necessarily caused 
by a complete inability to recruit Mad2, but may reflect an inability 
to detect it using SM2.2 either because the antibody is conforma-
tion specific (i.e., it cannot bind C-Mad2) or possibly because   
C-Mad2 is masked. If either possibility is true, an attractive hypoth-
esis emerges; if SM2.2 only detects O-Mad2 at kinetochores for 
whatever reason, perhaps Mps1 kinase activity is required to recruit   
O-Mad2 to the Mad1–C-Mad2 core complex. In this study, we test 
this hypothesis using a novel small molecule Mps1 inhibitor.
Results and discussion
AZ3146, a novel Mps1 inhibitor
To identify Mps1 inhibitors, we used a high throughput in vitro 
kinase assay to screen a compound collection, yielding an 
Figure  1.  AZ3146,  a  novel  Mps1  inhibitor. 
(A) AZ3146 (AZ) is shown. (B) In vitro kinase 
assay  measuring  the  ability  of  Mps1
Cat  to   
phosphorylate  myelin  basic  protein  (MBP).   
(C) In vitro kinase assays measuring the activity 
of Mps1 immunoprecipitated from nocodazole-
arrested HeLa cells. (D) Dose–response curve 
showing inhibition of Mps1
Cat by AZ3146.   
(E) Activity of AZ3146 against a kinase panel. 
(F) Phos tag immunoblot of Mps1 isolated from 
interphase  cells  or  nocodazole-arrested  cells 
treated with MG132 ± 2 µM AZ3146 for   
2 h. Arrowhead, major band; asterisk, minor 
band. Error bars indicate SEM derived from 
three experiments.27 Sustained Mps1 activity recruits O-Mad2 • Hewitt et al.
Although AZ3146 had a dramatic effect on kinetochore localiza-
tion of Mad2, reducing its levels to 15%, its effect on Mad1 was 
less pronounced, with levels remaining at 60% (Fig. 2, C and D). 
These data are entirely consistent with our prior observations, 
namely a dramatic inhibition of Mad2 and a partial effect on 
Mad1 (Tighe et al., 2008). Thus, taking together the enzyme 
data, the SAC override phenotype, and the effect on Mad1 
and Mad2 localization, these data show that AZ3146 behaves as 
one would predict for an Mps1 inhibitor, strongly arguing that it 
is a useful tool for probing Mps1 function.
Mps1 plays two roles when recruiting 
Mad1 and Mad2 to kinetochores
We were puzzled why inhibiting Mps1 had a dramatic effect on 
kinetochore  localization  of  Mad2  but  only  partially  effected 
Mad1. Indeed, other studies suggest that Mps1 inhibition does 
AZ3146 overrides the spindle checkpoint
Cell  cycle  analysis  showed  that  HeLa  cells  treated  with  no-
codazole and 2 µM AZ3146 only delayed mitosis briefly and 
then rereplicated their genomes (Fig. S2, A–C), demonstrating 
that the drug overrides the SAC. AZ3146 also silenced an al-
ready established SAC signal; after release from a nocodazole 
block, AZ3146 dramatically accelerated mitotic exit (Fig. S2 D). 
This was blocked by MG132, a proteasome inhibitor (Fig. S2 E), 
ruling out direct inhibition of Cdk1 activity. Time-lapse analysis 
of HeLa cells expressing a GFP-tagged histone showed that   
during an otherwise unperturbed mitosis, AZ3146 reduced the 
time to complete mitosis from 90 min in controls to 32 min   
(Fig. 2 A). Strikingly, 90% of AZ3146-treated cells underwent 
abnormal mitoses; although 50% entered anaphase without   
aligning all of their chromosomes, 30% exited mitosis with-
out undergoing obvious chromosome segregation (Fig. 2 B).   
Figure 2.  AZ3146 compromises SAC function 
and inhibits Mad2 localization. (A) Box and 
whisker  plot  of  HeLa  GFP-H2B  cells  treated 
with or without AZ3146 (AZ) and analyzed 
by  time-lapse  microscopy,  showing  the  time 
from nuclear envelope breakdown to chromo-
some  decondensation.  Values  were  derived 
from ≥75 cells. (B) Bar graph quantifying mi-
totic  phenotypes.  Values  were  derived  from 
≥115 cells. (C) Images of HeLa cells treated 
with nocodazole and MG132 for 2 h with or 
without AZ3146, fixed, and stained to detect 
centromeres (ACA) and either Bub1, Mad1, 
or  Mad2.  Insets  show  higher  magnification 
views of individual kinetochore pairs (boxed 
regions). (D) Bar graph quantifying pixel in-
tensities  at  kinetochores  normalized  to  ACA 
in  mitotic  HeLa  cells  treated  with  or  without 
AZ3146.  Values  were  derived  from  ≥228 
kinetochores.  (E)  Bar  graphs  scoring  kineto-
chore staining of Mad1/2 as high, medium, 
or low after exposure to nocodazole (Noc) or 
MG132 (MG) plus either AZ3146 or reversine 
(Rev). Data were derived from a two experi-
ments in which at least 50 cells were counted 
per condition. (F) Images of HeLa cells stained 
to detect Zwilch and centromeres after expo-
sure to nocodazole, reversine, and MG132 in 
the sequences indicated. AZ3146 was used at 
2 µM and reversine at 500 nM. Ctrl, control. 
Error bars indicate SEM. Bars: (C and F) 5 µm; 
(C, insets) 0.5 µm.JCB • VOLUME 190 • NUMBER 1 • 2010   28
data showing that the Mad1–C-Mad2 interaction is very stable 
(Howell et al., 2004; Shah et al., 2004; Vink et al., 2006).   
Because a key step in checkpoint activation is recruitment of   
O-Mad2  to  kinetochore-bound  Mad1–C-Mad2  (Musacchio 
and Salmon, 2007), we hypothesized that perhaps Mps1 activ-
ity is required to recruit O-Mad2 to Mad1–C-Mad2 complexes 
already at kinetochores. In that case, upon Mps1 inhibition,   
kinetochore-bound Mad2 should only fall to 50% (Fig. 3 A), 
yet AZ3146 abolishes Mad2 localization (Fig. 2, C–E). There-
fore, we speculated that the Mad2 antibody SM2.2 does not ef-
ficiently detect C-Mad2 at the kinetochore either because the 
antibody cannot bind C-Mad2 or because the relevant epitopes 
are masked.
To  test  this,  we  generated  cells  expressing  Myc-tagged 
Mad2 (Fig. 3 B and Fig. S3 B), reasoning that anti-Myc antibodies 
might detect it regardless of conformation or cellular context.   
Interestingly, Mad1 and Mad2 localize to the nuclear envelope in 
interphase (Campbell et al., 2001; Shah et al., 2004), and although 
we could readily detect Mad2 there using anti-Myc antibodies, 
SM2.2 did not decorate the envelope (Fig. 3 C), suggesting that it 
does not recognize C-Mad2 when bound to Mad1. In mitosis, 
both anti-Myc antibodies and SM2.2 decorated kinetochores 
(Fig. 3 D). Significantly, although AZ3146 reduced SM2.2 signal 
to background levels, anti-Myc antibodies still gave obvious   
kinetochore staining (Fig. 3, D and E). Importantly, however, quan-
titation showed that anti-Myc staining was reduced to 45 ± 5%   
(Fig.  3  E),  i.e.,  approaching  the  50%  value  predicted  by   
our hypothesis.
To test the hypothesis further, we analyzed two Mad2 mu-
tants. Mad2C cannot adopt the closed conformation (Mapelli   
et al., 2007) or bind Mad1 and, thus, can only bind kinetochores 
via dimerizing with endogenous C-Mad2 (Fig. 3 A). Mad2RQ 
can bind Mad1 but cannot dimerize (Mapelli et al., 2007) and, 
thus, can only target kinetochores by binding Mad1 (Fig. 3 A).   
If Mps1 is required to recruit O-Mad2 to the core, upon exposure to 
AZ3146, Mad2C should be absent from kinetochores, whereas 
Mad2RQ should be unaffected (Fig. 3 A). We generated stable 
cell lines expressing Myc-Mad2C and Myc-Mad2RQ (Fig. 3 B 
and Fig. S3 B). Although both mutants localized to kinetochores 
in mitosis (Fig. 3 D), Myc-Mad2C did not bind the nuclear en-
velope (Fig. S3 C). However, consistent with our hypothesis in 
response to AZ3146, Mad2C was no longer abundant at kineto-
chores, whereas Mad2RQ appeared unaffected (Fig. 3 D). Indeed, 
quantitation showed that Myc-Mad2C was reduced to a back-
ground  level,  whereas  Myc-Mad2RQ  remained  at  90% 
(Fig. 3 E). Thus, these observations strongly support the notion 
that during mitosis, Mps1 kinase activity is required to recruit   
O-Mad2 to kinetochore-bound Mad1–C-Mad2.
Mps1 is required for  
chromosome alignment
To confirm and further probe the role of Mps1 in chromosome 
alignment (Maure et al., 2007; Jelluma et al., 2008b), we ana-
lyzed the effect of AZ3146 after a monastrol washout (Mayer   
et al., 1999; Kapoor et al., 2006). Note that cells were also treated 
with MG132 to prevent mitotic exit caused by SAC override.   
Under these conditions, AZ3146 inhibited chromosome alignment 
dramatically affect Mad1 (Jelluma et al., 2008b; Kwiatkowski   
et al., 2010; Sliedrecht et al., 2010); e.g., inhibition of Mps1 using 
another small molecule, reversine, blocked recruitment of Mad1 
and its kinetochore receptor, the Rod–Zw10–Zwilch (RZZ) 
complex (Santaguida et al., 2010). We reasoned that these dif-
ferences may be a result of when Mps1 was first inhibited either 
before or during mitosis. To test this, we designed three experi-
ments, exposing cells to nocodazole, MG132, and AZ3146, but 
in different orders. After treatment, cells were fixed, stained, and 
the intensity of Mad1 at kinetochores was scored as high, me-
dium, or low (Fig. S3 A).
First, we treated cells with nocodazole and AZ3146 for   
2 h, adding MG132 for the last hour. Like our previous experi-
ments, in this regimen, some cells should enter mitosis in the 
presence of AZ3146, whereas others would already be in mito-
sis. This yielded a mixed effect on Mad1: although some cells 
still had high levels of Mad1 at kinetochores, others had low 
levels (Fig. 2 E, Expt. 1). Thus, the aforementioned partial ef-
fect on Mad1 (Fig. 2 D) appears to arise from the fact that when 
we quantitate pixel intensities in a small population of cells, 
some have relatively normal levels of Mad1 at kinetochores, 
whereas in others, it is markedly reduced (Fig. S3 A). Next,   
we treated cells with nocodazole and MG132 for 2 h, adding 
AZ3146 for the last hour. Because MG132 blocks entry into and 
exit out of mitosis, in this regimen, all mitotic cells should have 
entered mitosis before AZ3146 exposure. Under these condi-
tions, Mad1 was now largely unaffected (Fig. 2 E, Expt. 2).   
Finally, we treated cells with MG132 for 2 h, adding nocodazole 
and AZ3146 for the last hour. In this regimen, before AZ3146 
treatment, all mitotic cells should have aligned chromosomes 
with kinetochores stripped of Mad1/2 (DeLuca et al., 2003). 
Therefore,  adding  nocodazole  to  destabilize  microtubules 
should lead to rerecruitment of Mad1. Significantly, although 
Mad1 was present at kinetochores in controls, kinetochores in 
cells treated with nocodazole plus AZ3146 were devoid of 
Mad1 (Fig. 2 E, Expt. 3). Note that AZ3146 inhibited kineto-
chore localization of Mad2 regardless of the experimental   
regimen (Fig. 2 E).
The simplest explanation for these data is that Mps1 is in-
volved in two distinct steps. First, it is required upon mitotic   
entry to get Mad1 to kinetochores (or, in the case of experiment 3,   
it is required in mitosis to rerecruit Mad1 when microtubules 
are removed from attached kinetochores). Although Mps1 activ-
ity is no longer needed to maintain Mad1 localization, it is 
continuously required during mitosis to promote Mad2 recruit-
ment. Importantly, reversine yielded virtually identical pheno-
types (Fig. 2 E). Furthermore, when cells were treated with 
reversine before mitotic entry, the RZZ component Zwilch was 
largely absent from kinetochores (Fig. 2 F). However, when 
cells accumulated in mitosis before exposure to reversine, 
Zwilch localization was normal.
Mps1 activity is required to recruit  
O-Mad2 to the Mad1–C-Mad2 core
The aforementioned data suggest that during mitosis, Mps1 activ-
ity is required continuously to recruit Mad2 to kinetochore-
bound Mad1 (Fig. 2 E, Expt. 2). However, this notion contradicts 29 Sustained Mps1 activity recruits O-Mad2 • Hewitt et al.
efficient chromosome alignment, whereas the severe phenotype, 
at least in some cells, may be a consequence of the prolonged 
mitotic arrest.
Mps1 activity is required for centromere 
protein E (CENP-E) localization
In light of Mps1 regulating aurora B via borealin phosphoryla-
tion (Jelluma et al., 2008b), we were surprised that the alignment 
in >85% of cells (Fig. 4, A and B), yielding either a mild pheno-
type with few unaligned chromosomes or a severe phenotype with   
most chromosomes near the poles (Fig. 4 A). Time-lapse micros-
copy showed that AZ3146-treated cells typically aligned all   
but a few chromosomes (Fig. 4 C, 96 min). However, sometime 
later, sister chromatids appeared to separate followed by rather 
chaotic attempts to realign (Fig. 4 C, 184 min; and Fig. S2 F). 
Thus, the mild phenotype appears to reflect Mps1’s role in 
Figure 3.  AZ3146 inhibits kinetochore recruitment of O-Mad2. (A) A scheme is shown predicting the behavior of endogenous Mad2 and Myc-tagged 
mutants in cells after inhibition of Mps1 activity. (B) Immunoblots of Tet-induced HeLa lines probed to detect Mad2. (C) Images of an interphase HeLa cell 
expressing Myc-Mad2 wild type stained to detect Mad1, Mad2 using SM2.2, and an anti-Myc antibody. (D) Images of nocodazole-treated cells stained to 
detect the Myc tag (red), Mad2 (green), and centromeres (ACA; blue) after a 2-h exposure to 2 µM AZ3146 (AZ) and MG132. Insets show higher magnifi-
cation views of individual kinetochore pairs (boxed regions). (E) Bar graph quantitating either Mad2 (red) or Myc tag (blue) pixel intensities at kinetochores 
normalized to ACA. WT, wild type; RQ, Mad2RQ. Values indicate SEM derived from ≥245 kinetochores. Bars: (C and D) 5 µm; (C, insets) 0.5 µm.JCB • VOLUME 190 • NUMBER 1 • 2010   30
Figure 4.  AZ3146 inhibits chromosome alignment. (A) Images of HeLa cells stained to detect the chromosomes (blue), tubulin (red), and aurora B (green) 
after monastrol washout into 2 µM AZ3146 (AZ) and MG132 for 90 min. (B) Bar graph quantitating the mitotic phenotypes observed after monastrol 
washout into AZ3146 or ZM447439 (ZM). Values were derived from ≥115 cells in three independent experiments. Ctrl, control. (C) Time-lapse sequences 
of GFP-H2B HeLa cells after monastrol washout into AZ3146 and MG132. Numbers represent minutes after monastrol washout. (D) Images of HeLa cells 
stained to detect the chromosomes (red), aurora A (green/blue), CENP-E (red), and centromeres (ACA; green) after monastrol washout into AZ3146 and 
MG132 for 60 min. Insets show higher magnification views of individual kinetochore pairs (boxed regions). (E) Bar graph quantitating CENP-E staining 
normalized to ACA at polar kinetochores in AZ3146-treated cells. The mean control value is normalized to 100%. At least 300 polar kinetochores were 
analyzed in ≥23 cells. Error bars indicate SEM. Bars: (A, C, and D) 5 µm; (D, insets) 0.5 µm.31 Sustained Mps1 activity recruits O-Mad2 • Hewitt et al.
inactive, the Myc-Mps1 band shift was absent (Fig. 5 F, lane 4). 
Together, these observations support the notion that Mps1 does 
dimerize and transphosphorylate in mitotic cells. Whether this 
regulates its localization requires further investigation.
Coupling SAC signaling with  
chromosome congression
Our observations suggest a two-step role for Mps1. Around the 
onset of mitosis, Mps1 activity is required to first recruit the 
Mad1–C-Mad2 core to kinetochores, possibly indirectly by pro-
moting RZZ recruitment. During mitosis, Mps1 activity is con-
tinuously required to recruit O-Mad2 to the Mad1–C-Mad2 core. 
Although Mps1 may achieve this directly, e.g., by phosphorylat-
ing the core or O-Mad2, this seems unlikely because the Mad2 
template mechanism can be recapitulated in vitro without Mps1 
activity (Vink et al., 2006). Therefore, perhaps Mps1 kinase   
activity counters a cellular inhibitor not present in these in vitro 
assays. Interestingly, p31
comet may act as an inhibitory “cap” on the 
Mad1–C-Mad2 core (Musacchio and Salmon, 2007). Thus, an 
attractive hypothesis is that Mps1 phosphorylates and inactivates 
p31
comet, removing the inhibitory cap to allow recruitment of   
O-Mad2 and thereby kick starting the Mad2 template reaction. 
However, we presently have no evidence linking Mps1 and 
p31
comet. As Mps1 levels at kinetochores increase when its activ-
ity is blocked, perhaps Mps1 is itself an inhibitory cap that must 
be released for checkpoint signaling. Having first recruited the 
Mad1–C-Mad2 core, perhaps Mps1 transphosphorylation pro-
motes an autorelease mechanism that allows recruitment of   
O-Mad2, kick starting the Mad2 template mechanism.
We confirm a role for Mps1 activity in chromosome align-
ment. Although we observe no obvious effect on aurora B func-
tion, Mps1 activity is clearly required for CENP-E recruitment after 
monastrol  washout.  Interestingly,  however,  Mps1-RNAi  did  not 
prevent CENP-E recruitment (Jelluma et al., 2008b; Tighe et al., 
2008). Because inactive Mps1 accumulates at kinetochores, perhaps 
Mps1 and CENP-E occupy mutually exclusive binding sites. In this 
scenario, Mps1 autorelease would normally expose the CENP-E–
binding site. However, when its catalytic activity is inhibited, Mps1 
blocks CENP-E recruitment by remaining bound to the kinetochore. 
In contrast, when the entire Mps1 protein is depleted by RNAi, the 
CENP-E–binding site is vacant, allowing its recruitment. Consistent 
with this notion, the levels of kinetochore-bound CENP-E have been 
observed to increase after Mps1 depletion (Jelluma et al., 2008b). 
Although speculative, these ideas warrant further exploration and 
should provide interesting insights into how Mps1 coordinates spin-
dle checkpoint signaling and chromosome congression.
Materials and methods
Inhibitor screen
N-terminal GST-tagged full-length human Mps1 kinase (GenBank accession 
no. NM_003318) was expressed in insect cells and purified via the GST epi-
tope tag. A 12 µl mixture of recombinant enzyme, an FITC-labeled peptide 
substrate (FITC-DHTGFLTEYVATR-CONH2), 12 µM ATP, and a buffer solution 
(50 mM Hepes, pH 7.5, 0.015% vol/vol Brij-35, 1 mM DTT, and 10 mM 
MgCl2)  were  incubated  with  test  compounds  at  room  temperature  for   
25 min. Test compounds were prepared and further diluted in DMSO and 
placed into 384-well low volume white polystyrene plates (Greiner) using an 
acoustic liquid handler (Echo; Labcyte, Inc.). Reactions were stopped by the 
defect was not typical of that observed after aurora B inhibition 
(Ditchfield et al., 2003). Indeed, AZ3146 had no obvious effect 
on several bona fide aurora B substrates (Fig. S1, D–F). There-
fore, we turned our attention to other factors to explain the   
chromosome alignment defect. The phenotype observed in 
AZ3146-treated cells is quite exquisite; most chromosomes align, 
K-fibers are evident (Fig. 4 A), and only a few chromosomes re-
main near the spindle poles (Fig. 4, A–C). This reminded us of the 
phenotype  typical  of  CENP-E  inhibition  (Wood  et  al.,  1997; 
Weaver et al., 2003; Kapoor et al., 2006). Strikingly, 1 h after 
monastrol washout, the level of CENP-E at kinetochores was re-
duced to 10% (Fig. 4, D and E). Consistent with this being an 
on-target effect of AZ3146, when Mps1-RNAi cells were recon-
stituted with the Mps1
M602A allele, 1NM-PP1 inhibited kineto-
chore localization of CENP-E (Fig. S3 D). Thus, CENP-E appears 
to be an important downstream effector of Mps1 kinase activity. 
Note that this is entirely consistent with a previous study analyz-
ing Xenopus laevis egg extracts (Abrieu et al., 2001).
Inhibition of Mps1 increases its abundance 
at kinetochores
These data indicate that Mps1 contributes to mitotic fidelity by 
promoting kinetochore recruitment of O-Mad2 and Cenp-E.   
Although detailing the exact molecular mechanisms will require 
further experimentation, one observation may prove informative. 
In the presence of AZ3146, Mps1 staining at kinetochores   
increased by about sixfold (Fig. 5, A and B). This is not simply 
caused by increasing epitope accessibility, as direct fluorescence 
from a GFP-Mps1 fusion was also more evident at kinetochores 
in AZ3146-treated cells (Fig. 5 E).
To confirm that this reflected an on-target effect of AZ3146, 
we compared kinetochore localization of wild-type and kinase-
dead GFP-Mps1 fusions after repression of the endogenous ki-
nase by RNAi (Tighe et al., 2008). Strikingly, the kinase-dead 
mutant was about eightfold more abundant at kinetochores   
compared with wild-type (Fig. 5, C and D), supporting the notion 
that inhibiting Mps1’s activity does indeed increase its levels at 
kinetochores.  Because  FRAP  experiments  have  shown  that 
GFP-Mps1 has a relatively short residency time at kinetochores 
(Howell et al., 2004), one explanation is that inhibiting Mps1 activ-
ity reduces its turnover at kinetochores.
Mps1 dimerizes and transphosphorylates
Importantly, the GFP-Mps1 kinase-dead fusion only increased at 
kinetochores when we repressed the endogenous kinase (Fig. 5 C). 
Therefore, we wondered whether Mps1 functions as a dimer that 
requires transphosphorylation to be released from the kinetochore. 
Interestingly, Mps1 transphosphorylation has been demonstrated 
in vitro, but there is no evidence to support dimerization in cells 
(Kang et al., 2007). Therefore, we transiently transfected GFP-
tagged Mps1 into cells stably expressing Myc-tagged Mps1. Myc-
tagged proteins were immunoprecipitated and blotted to detect 
GFP. When we immunoprecipitated Myc-Mps1, GFP-Mps1 was 
readily detectable (Fig. 5 F and Fig. S3 E), which is consistent 
with dimerization. Interestingly, when either fusion was catalyti-
cally active, a portion of the Myc-tagged protein was phosphory-
lated (Fig. 5 F). In contrast, when both fusions were catalytically JCB • VOLUME 190 • NUMBER 1 • 2010   32
addition of 40 mM, 0.1% coating reagent (Caliper Life Sciences), 100 mM 
Hepes, pH 7.5, 0.015% vol/vol Brij-35, and 5% DMSO. Inhibitors of Mps1 
activity were identified using a microfluidic chip and laser-induced fluores-
cence (LabChip LC3000; Caliper Life Sciences) to measure the conversion of 
the fluorescent-labeled peptide to a phosphorylated product.
In vitro kinase assays
His-tagged human Mps1
Cat encoding amino acids 510–857 was gener-
ated as described previously (Chu et al., 2008). For kinase assays, 500 ng 
was added to buffer (25 mM Tris-HCl, pH 7.4, 100 mM NaCl, 50 µg/ml 
BSA, 0.1 mM EGTA, 0.1% -mercaptoethanol, 10 mM MgCl2, and 0.5 µg/ml 
Figure 5.  AZ3146 enhances kinetochore localization of Mps1. (A) Images of HeLa stained to detect Mps1 (red), centromeres (ACA; green), and the 
chromosomes after treatment with nocodazole and MG132 for 2 h ± 2 µM AZ3146 (AZ). (B) Bar graph quantitating Mps1 at kinetochores normal-
ized to ACA. Values were derived from ≥345 kinetochores in ≥18 cells with the mean in control cells normalized to 100%. (C) Images of HeLa cells 
expressing GFP-Mps1, either wild type (WT) or kinase dead (KD), stained to detect GFP-Mps1 (green), centromeres (ACA; red), and chromosomes. Note 
that endogenous Mps1 was first repressed by RNAi. Before fixation, cells were treated with nocodazole and MG132 for 2 h with or without AZ3146.   
(D) Bar graph quantitating GFP pixel intensities at kinetochores normalized to ACA. Values were derived from ≥240 kinetochores in ≥17 cells with the 
mean in controls cells normalized to 100%. (E) Images of HeLa cells expressing GFP-Mps1 treated with or without AZ3146 and a bar graph scoring direct 
GFP fluorescence from kinetochores as high, medium, or low are shown. Data are representative of two independent experiments in which ≥50 cells 
were counted. Ctrl, control. (F) Immunoblots of anti-Myc immune complexes isolated from HEK293 cells stably expressing Myc-tagged Mps1 transgenes 
and transiently transfected with vectors encoding GFP-tagged Mps1 transgenes, either wild type or kinase dead. Membranes were blotted as indicated.   
IP, immunoprecipitation. (A and C) Insets show higher magnification views of individual kinetochore pairs (boxed regions). Error bars indicate SEM.   
Bars: (A, C, and E) 5 µm; (A and C, insets) 0.5 µm.33 Sustained Mps1 activity recruits O-Mad2 • Hewitt et al.
(Millipore), blocked in 5% milk, and primary antibodies were added over-
night.  After  washing  and  incubation  with  appropriate  secondary  anti-
bodies, proteins were visualized using chemiluminescence (SuperSignal; 
Thermo Fisher Scientific) and imaged on film (Biomax MR; Kodak). For   
immunofluorescence, cells grown on coverslips were fixed in 1% formalde-
hyde, quenched in glycine, pH 8.5, permeabilized using PBS plus 0.1% 
Triton X-100 (PBST), and incubated with primary antibodies. After washes 
in PBST and incubation with appropriate secondary antibodies, cells were 
counterstained with 1 µg/ml Hoechst 33358 in PBST and mounting in 90% 
glycerol and 20 mM Tris-HCl, pH 8.0. To visualize microtubules, cells were 
preextracted in 100 mM Pipes, 1 mM MgCl2, 0.1 mM CaCl2, and 0.1% 
Triton X-100 for 90 s before fixation in 4% formaldehyde in the same buffer 
for 10 min. To stain for CENP-E, cells were preextracted with a buffer con-
taining 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% BSA, and 0.2%   
Triton X-100 for 2 min before fixation with 4% formaldehyde in PBS (Chan   
et al., 2000). Phos tag (Wako Chemicals USA, Inc.) was used according 
to the manufacturer’s instructions. In brief, 25 µM Phos tag and 50 µM 
MnCl2 were added to standard SDS-PAGE gels containing 6% acrylamide 
and visualized by immunoblotting.
Image acquisition and processing
Immunofluorescence images were acquired at room temperature on a resto-
ration microscope (Delta Vision RT; Applied Precision) using a 100× 1.40 NA   
Plan Apo objective and a filter set (Sedat Quad; Chroma Technology 
Corp.). The images were collected at room temperature using a charge- 
coupled device camera (CoolSNAP HQ; Photometrics) with a z-optical spac-
ing of 0.2 µm. Raw images were deconvolved using the SoftWorx software 
(Applied Precision), and maximum intensity projections of these deconvolved 
images are described in Results and discussion. Time-lapse microscopy was 
performed on a manual microscope (Axiovert 200; Carl Zeiss, Inc.) equipped 
with an automated stage (PZ-2000; Applied Biosystems) and an environmen-
tal control chamber (Solent Scientific), which maintained the cells at 37°C in 
a humidified stream of 5% CO2. Imaging was performed using either a 32× 
0.40 NA long-distance A-Plan or a 40× 0.75 NA Neo Fluor objective. Shut-
ters, filter wheels, and point visiting were driven by MetaMorph software 
(Universal Imaging). Images were taken using a camera (CoolSNAP HQ; 
Photometrics), and individual tagged image file format files were imported 
into PhotoShop (Adobe) for printing or into QuickTime (Apple) for videos.
Online supplemental material
Fig. S1 shows that AZ3146 does not inhibit Cdk1 or aurora B. Fig. S2 
shows that AZ3146 overrides the spindle checkpoint. Fig. S3 shows that 
Mps1 activity is required for kinetochore localization of CENP-E. Table S1 
lists the PCR primers used in this study. Table S2 lists the antibodies used in 
this study. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201002133/DC1.
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otherwise stated.
Cell biology and RNAi
DNA content, mitotic index measurement, and synchronization of HeLa 
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conjugated donkey anti–mouse antibody (Jackson ImmunoResearch Labo-
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